🛡️ Public data only — no PHI permitted on this instance.

HOSP

NUERODIAGNOSTIC INSTITUTE

CCN 154008|LOC INDIANAPOLIS, IN|BEDS 159|NPR $29.3M|MARGIN -38.2%

SeekingChartis Score

INVESTMENT THESIS

Pass: NUERODIAGNOSTIC INSTITUTE

/ 100 (D)

+$2.2M

EBITDA Uplift

+736bps

Margin Δ

0.0%

Op Margin

$29.3M

Revenue

—

Realization

—

Peer Rank

SIGNAL STRENGTH

Margin

0.0%

Safety

nan%

CATALYSTS

RISKS

▼High Medicaid exposure (40%)

Speculative — only pursue if turnaround thesis is strong and entry multiple reflects risk.

Peer Analysis EBITDA Bridge Data Room IC Memo ML Detail

$29.3M

Net Patient Revenue

-38.2%

Operating Margin

$-11.2M

Net Income

159

Licensed Beds

$184K

Revenue per Bed

$40.5M

Operating Expenses

Payer Mix

PYR

■ MEDICARE · nan%■ MEDICAID · 40%■ COMMERCIAL · 0%

Score Breakdown

SCComposite · 18/100

Component	Score	Max	%
Market Position	12	35	35%
Financial Health	0	25	0%
Operational Quality	0	20	0%
Competitive Moat	2	20	11%

Comparable Hospitals

CMP

CCN	Hospital	Beds	NPR
150001	JOHNSON MEMORIAL HOSPITAL	58	$0M
150002	METHODIST HOSPITALS INC	405	$0M
150004	FRANCISCAN HEALTH HAMMOND	10	$0M
150005	HENDRICKS REGIONAL HEALTH	130	$0M
150006	LAPORTE HOSPITAL	74	$0M

Team Notes

NOTE0 entries

Actions

ACT

WFDiligence Workflow

Competitive Intel EBITDA Bridge Data Room IC Memo Scenarios

AIDeep Analysis

ML Analysis Demand 3-Year History Stats Bayesian

FINFinancial Models

DCF LBO 3-Statement Returns Market Denial

MORE IN INStart Diligence · creates a deal from HCRIS